10/11/2011 - 1:04pm

About half of people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study.

10/11/2011 - 1:04pm

“Dispense-as-written” prescriptions are exacerbating medication nonadherence and costing the U.S. healthcare system up to $7.7 billion annually, according to a study by researchers at Harvard University, Brigham and Women’s Hospital, and CVS Caremark.


10/11/2011 - 1:04pm

Patients with one or more of four chronic diseases who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to the findings of a CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.


10/11/2011 - 1:04pm

A CVS Caremark-sponsored study looking at in-person, electronic, telephone, fax and mail communications that counsel patients to stay on their medications found that pharmacists in a retail setting are the most influential healthcare “voices” in promoting medication adherence.


10/11/2011 - 1:04pm

Patients with chronic heart disease are likely to have several doctors and take nearly a dozen medications that are filled in at least two different pharmacies, resulting in many patients struggling to keep their medications straight, according to a new study.


10/11/2011 - 1:04pm

How much adherence lowers total costs, why some patients do not take their medications as prescribed and whether what’s saved in health care offsets higher drug costs are among the questions that have not been as clearly understood.


10/11/2011 - 1:04pm

CVS Caremark’s MinuteClinic continues to evolve and play a greater role in the U.S. healthcare system as evidenced by its expanding footprint, broadening scope of service and growing roster of strategic affiliations.


10/11/2011 - 1:04pm

At press time, the industry was weighing the potential merger of pharmacy benefit manager rivals Express Scripts and Medco Health Solutions, but executives at CVS Caremark remain more confident than ever that its PBM business is ideally positioned to “effectively compete."


10/11/2011 - 1:04pm

Private-label penetration at CVS/pharmacy locations is expected to grow to more than 20% in the next two to three years, and to help drive that growth, the retailer has developed its new Just the Basics line of store-brand products.